Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma of the Ovary”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Ended earlyNCT03164980
What this trial is testing

QoL-Comparison Between Trabectedin/PLD and Pt-based Therapy in Patients With Pt-sensitive Recurrent Ovarian Cancer

Who this might be right for
Quality of LifeOvarian CancerRecurrent Ovarian Carcinoma
North Eastern German Society of Gynaecological Oncology 89
Testing effectiveness (Phase 2)Study completedNCT01580696
What this trial is testing

Phase I/IIa Trial of Folate Binding Protein Vaccine in Ovarian Cancer

Who this might be right for
Ovarian CancerEndometrial CancerFallopian Cancer+1 more
COL George Peoples, MD, FACS 51
Not applicableStudy completedNCT01734746
What this trial is testing

Sentinel Node Detection in Clinical Early Stage Ovarian Cancer

Who this might be right for
Ovarian CancerSentinel Node
Maastricht University Medical Center 22
Testing effectiveness (Phase 2)Study completedNCT01616303
What this trial is testing

A Controlled Study of the Effectiveness of Oregovomab (Antibody) Plus Chemotherapy in Advanced Ovarian Cancer

Who this might be right for
Ovarian Neoplasms
Quest PharmaTech Inc. 97
Testing effectiveness (Phase 2)WithdrawnNCT01661868
What this trial is testing

Olaparib for Patients With Recurrent BRCA Deficient Ovarian Cancer

Who this might be right for
Ovarian CancerPeritoneal CancerFallopian Tube Cancer
Dana-Farber Cancer Institute
Large-scale testing (Phase 3)Study completedNCT00483782
What this trial is testing

Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Newly Diagnosed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Medical Research Council 1,520
Large-scale testing (Phase 3)Study completedNCT02631876
What this trial is testing

Mirvetuximab Soravtansine vs. Investigator's Choice of Chemotherapy in Women With Folate Receptor (FR) Alpha Positive Advanced Epithelial Ovarian Cancer (EOC), Primary Peritoneal or Fallopian Tube Cancer

Who this might be right for
Epithelial Ovarian CancerPrimary Peritoneal CarcinomaFallopian Tube Cancer+1 more
ImmunoGen, Inc. 366
Not applicableUnknownNCT00155740
What this trial is testing

Mesothelin as a New Tumor Marker for Ovarian Cancer

Who this might be right for
Ovarian Cancer
National Taiwan University Hospital 250
Testing effectiveness (Phase 2)Study completedNCT03901118
What this trial is testing

Chiauranib in Combination With Chemotherapy in Patients With Ovarian Cancer

Who this might be right for
Ovarian Cancer
Chipscreen Biosciences, Ltd. 47
Large-scale testing (Phase 3)WithdrawnNCT04795596
What this trial is testing

Secondary Cytoreductive Surgery in Platinum-resistant Recurrent Ovarian Cancers

Who this might be right for
Ovarian CancerRecurrent Ovarian Carcinoma
Menoufia University
Early research (Phase 1)Study completedNCT00959582
What this trial is testing

Positron Emission Tomography/Computed Tomography (PET/CT) in Relapsed Ovarian Cancer (MK-0000-143)

Who this might be right for
Ovarian CancerPrimary Peritoneal CancerFallopian Tube Cancer
Merck Sharp & Dohme LLC 42
Not applicableLooking for participantsNCT06760923
What this trial is testing

Urinary Proteomic Assessment of Ovarian Malignancy and Disease Progression

Who this might be right for
Ovarian Cancer (OvCa)
Xiangya Hospital of Central South University 240
Testing effectiveness (Phase 2)Study completedNCT00004876
What this trial is testing

Carboplatin With or Without Thalidomide in Treating Patients With Ovarian Epithelial Cancer

Who this might be right for
Ovarian Cancer
Cancer Research UK 30
Testing effectiveness (Phase 2)UnknownNCT03924882
What this trial is testing

Anlotinib for Patients With Platinum Resistant or Refractory Ovarian Cancer

Who this might be right for
Ovarian Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine 30
Testing effectiveness (Phase 2)UnknownNCT01772979
What this trial is testing

Study With Trabectedin in BRCA1 and BRCA2 Mutation Carrier and BRCAness Phenotype Ovarian Cancer

Who this might be right for
BRCA1 and BRCA2 Mutation Carrier and BRCAness Phenotype
Catholic University of the Sacred Heart 100
Not applicableWithdrawnNCT02878980
What this trial is testing

An Exercise Intervention Trial to Reduce Symptoms & Improve Clinical Outcomes of Platinum-Based Treatment in Ovarian Cancer Patients

Who this might be right for
Ovarian Carcinoma
City of Hope Medical Center
Early research (Phase 1)Ended earlyNCT01243762
What this trial is testing

Dalotuzumab + MK-2206, Dalotuzumab + MK-0752, and Dalotuzumab + Ridaforolimus Combination Therapies in Participants With Advanced Cancer (MK-0646-027)

Who this might be right for
Neoplasms Malignant
Merck Sharp & Dohme LLC 47
Testing effectiveness (Phase 2)UnknownNCT05272462
What this trial is testing

Oral Minoxidil for the Treatment of Recurrent Platinum Resistant Epithelial Ovarian Cancer

Who this might be right for
Ovarian Cancer
Loyola University 34
Testing effectiveness (Phase 2)Looking for participantsNCT05503797
What this trial is testing

Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

Who this might be right for
Cancer Harboring BRAF AlterationsHGGLGG+1 more
Fore Biotherapeutics 254
Not applicableUnknownNCT05212779
What this trial is testing

Predicting the Risk of Ovarian Cancer Recurrence Using Circulating Tumor DNA to Assess Residual Disease

Who this might be right for
Epithelial Ovarian Cancer
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) 45
Next Page